Universidade de São Paulo, Faculdade de Medicina, Divisão de Neurologia, São Paulo, SP, Brazil.
Universidade de São Paulo, Faculdade de Medicina, Instituto de Radiologia São Paulo, SP, Brazil.
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):143-158. doi: 10.1590/0004-282X-ANP-2022-S122.
Autoimmune encephalitis (AE) comprises a group of diseases mediated by antibodies against neuronal cell surface or synaptic antigens, such as ion channels or neurotransmitter receptors. New clinical syndromes and their associated antibodies were and are still being characterized over the last two decades. The fact that their main clinical features are interdisciplinary, - encompassing neuropsychiatric symptoms, cognitive dysfunction, epileptic seizures, movement and sleep disorders - has led to a surge of interest in this field. Some of these diseases present with a well-defined syndrome, being recognizable on clinical grounds. Correct diagnosis is important since AE are potentially treatable diseases, despite their severity. On the other hand, an increasing number of neuronal antibodies being described casts doubt upon the way we should utilize antibody testing and interpret results. In this article we review, summarize and update the current knowledge on antibody mediated encephalitis.
自身免疫性脑炎 (AE) 是一组由针对神经元细胞表面或突触抗原的抗体介导的疾病,例如离子通道或神经递质受体。在过去的二十年中,新的临床综合征及其相关抗体不断被发现和描述。这些疾病的主要临床特征是跨学科的,包括神经精神症状、认知功能障碍、癫痫发作、运动和睡眠障碍,这导致了人们对该领域的浓厚兴趣。其中一些疾病表现出明确的综合征,可以通过临床依据识别。正确的诊断很重要,因为尽管 AE 很严重,但它们是可以治疗的疾病。另一方面,越来越多的神经元抗体被描述,这使得我们对抗体检测和结果解读的方式产生了怀疑。在本文中,我们回顾、总结和更新了目前关于抗体介导性脑炎的知识。